US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist

3.150
+0.590+23.04%

Trading Oct 15 14:11 ET

17.11MMarket Cap-1046P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aprea Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	561.570K / 33.330K	--
--	2024/Q1	380.570K / 0.000	--
--	2023/Q4	14.080K / 100.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q2561.570K / 33.330K--

--2024/Q1380.570K / 0.000--

--2023/Q414.080K / 100.000K--

Unlock Free Earnings Estimates

Open Account

Aprea Therapeutics Earnings Reports

Aprea Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 08:40 ET

Aprea Therapeutics | 10-Q: Q1 2024 Earnings Report

May 14 08:39 ET

Aprea Therapeutics | 10-K: FY2023 Annual Report

Mar 26 07:49 ET

Aprea Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 9, 2023 16:10 ET

Analyst Rating

Updated: Sep 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall